You are on page 1of 1

Case Study: Autologous stem cell treatment via peripheral blood harvest in a 81 male for stroke rehabiliation The

patient has a history of right sided CVA who underwent a peripheral infusion of autologous stem cells on 30th March 2013. He was found upon presentation wheelchair bound suffering clinically from a past significant CVA which resulting in marked right-sided hemi-neglect and severe Dysarthria. He required trunk support whist sitting as noted and had limited right leg extension prior to the transplant. His pathology did note a positive mycoplasma culture, he was well clinically well however and both lung bases upon examination were clear and nil fevers or temps present. Oxygen saturations were all normal. 250ml of blood was taken via venipuncture with a 16 gauge catheter which was then transported to the labs of Autologous Stem Cell Technology for the autologous stem cell conversion. Peripheral infusion of the converted cells took place on the 30th March, 2013 through an IV infusion in his forearm without complication. He was discharged from my care stable and well and returned to his residence the same day with his attending RN and family. He was prophylactically discharged with a drug order for Rulide 150mg bd to cover this which was continued with thanks by his LMO at his Nursing Home. All observations and vital signs were stable both pre and post to the stem cell transplant. Patient was followed up approximately 6 weeks later. Patient continues to recover with supportive and intensive speech pathology and physiotherapy sessions to improve his strength, motor and speech and balance control. It is recommended that suitable imaging studies such as MRI or CT to document any potential changes to ischaemic infracted, cognitive change on areas post transplant be arranged at perhaps 3 and 6 months as per his Neurologists advice.

Dr Kellie Scheuner B.Biomed.Sc (Hons) MB BS (Hons) Attending Medical Practitioner

You might also like